Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Information on the total number of voting rights and shares

  • Read more about Information on the total number of voting rights and shares

Bone Therapeutics accelerates its ALLOB® Phase I/IIA Delayed-Union trial

  • Read more about Bone Therapeutics accelerates its ALLOB® Phase I/IIA Delayed-Union trial

Bone Therapeutics treats first patients in ALLOB® Phase IIA spinal fusion trial

  • Read more about Bone Therapeutics treats first patients in ALLOB® Phase IIA spinal fusion trial

Bone Therapeutics Establishes US Subsidiary

  • Read more about Bone Therapeutics Establishes US Subsidiary

Bone Therapeutics officially opens its new headquarters in Gosselies

  • Read more about Bone Therapeutics officially opens its new headquarters in Gosselies

Bone Therapeutics Reports 2014 Financial and Operational Results

  • Read more about Bone Therapeutics Reports 2014 Financial and Operational Results

Bone Therapeutics Provides Business Update for the First Quarter 2015

  • Read more about Bone Therapeutics Provides Business Update for the First Quarter 2015

Bone Therapeutics reports first results of its Phase IIA trial for PREOB® in severe osteoporosis

  • Read more about Bone Therapeutics reports first results of its Phase IIA trial for PREOB® in severe osteoporosis

Bone Therapeutics treats second patient cohort in ALLOB® Phase I/IIA delayed-union fracture trial

  • Read more about Bone Therapeutics treats second patient cohort in ALLOB® Phase I/IIA delayed-union fracture trial

Bone Therapeutics Notice of Half Year Results 2015

  • Read more about Bone Therapeutics Notice of Half Year Results 2015

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions